Unicycive Therapeutics annual revenue
2022
2023
2024
2025
Unicycive Therapeutics Revenue Growth & History (UNCY)
Unicycive Therapeutics reported $0 in revenue for fiscal 2025.
View full Unicycive Therapeutics company overviewUnicycive Therapeutics annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $0 | $0 | — |
| 2024 | 2024-12-31 | $0 | −$675,000 | −100.00% |
| 2023 | 2023-12-31 | $675,000 | −$276,000 | −29.02% |
| 2022 | 2022-12-31 | $951,000 | — | — |
Unicycive Therapeutics quarterly revenue
Q3.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0 | $0 | — |
| Q1 2026 | 2026-03-31 | $0 | $0 | — |
| Q4 2025 | 2025-12-31 | $0 | — | — |
| Q3 2025 | 2025-09-30 | $0 | — | — |
| Q2 2025 | 2025-06-30 | $0 | — | — |
| Q1 2025 | 2025-03-31 | $0 | — | — |
| Q4 2023 | 2023-12-31 | $0 | — | — |
| Q3 2023 | 2023-09-30 | $0 | −$951,000 | −100.00% |
| Q2 2023 | 2023-06-30 | $0 | — | — |
| Q1 2023 | 2023-03-31 | $675,000 | — | — |
| Q3 2022 | 2022-09-30 | $951,000 | — | — |
Unicycive Therapeutics revenue growth trends
Unicycive Therapeutics's latest reported quarter, Q2 2026, generated $0 in revenue.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Unicycive Therapeutics source filings ↗Community posts
Unicycive resubmits kidney-drug application with new manufacturer data
Unicycive ($UNCY) resubmitted its US application for oxylanthanum carbonate, an investigational oral phosphate binder for dialysis patients with chronic kidney disease. The package includes manufacturing and quality data from a new third-pa ...
